|
|
Clinical Prognostic Study on Intermediary Thrombolytic Therapy for Acute Ischemic Stroke Based on CTP |
Zheng Jianghuan1, Wu Bangwu2, Yang Yingjing1 |
1. The Second Affiliated Hospital of Guizhou Medical University, Qiandongnan 556000, China; 2. Liping County People’s Hospital, Qiandongnan Prefecture, Guizhou 557300, China; |
|
|
Abstract Objective To investigate the prognostic evaluation value of CTP technology in AIS patients undergoing interventional thrombectomy. Method Clinical data of 83 AIS patients undergoing MT surgery were collected for retrospective analysis.They were divided into a good prognosis group of 52 cases and a poor prognosis group of 31 cases according to the mRS score.According to the mCTA score, they were divided into a good collateral circulation group of 54 cases and a poor collateral circulation group of 29 cases.According to the NIHSS score, they were divided into a significantly improved nerve defect group of 48 cases and a no significant improvement nerve defect group of 35 cases.The CTP perfusion parameters of patients in different groups were compared one week after surgery. Result The CTP perfusion parameters CBF, CBV, and HIR values of patients with good prognosis were significantly higher than those of patients with poor prognosis(P< 0.05); The CTP perfusion parameters CBF, CBV, and HIR values of patients with good collateral circulation were significantly higher than those of patients with poor collateral circulation(P< 0.05); The CTP perfusion parameters CBF, CBV, and HIR values of patients with significantly improved neurological deficits were significantly higher than those of patients with no significant improvement in neurological deficits(P< 0.05). Conclusion CTP technology can effectively evaluate the postoperative collateral circulation status, degree of neurological dysfunction, and overall prognosis of AIS patients undergoing MT surgery by measuring parameters such as infarct core volume and ischemic penumbra.It provides a scientific reference for clinical prediction of HT risk and the formulation of next step treatment plans.
|
Received: 24 July 2023
|
|
|
|
|
[1] 陈华, 张继, 张波, 等.急性缺血性脑卒中取栓前后CT灌注成像与复发及认知功能的相关性分析[J].河北医学, 2022, 28(12):2052-2058. [2] 钟景云, 鲁俊, 苏佳娜.脑部CT及MRI在脑血管取栓术中的评估应用[J].影像技术, 2023, 35(1):10-15. [3] 刘伟, 黄泽玉, 宫立新等.急性缺血性脑卒中溶栓后出血患者的预后及CT灌注成像研究[J].中国实用神经疾病杂志, 2023, 26(7):836-841. [4] 钟迪, 张舒婷, 吴波.《中国急性缺血性脑卒中诊治指南2018》解读[J].中国现代神经疾病杂志, 2019, 19(11):897-901. [5] 国家卫生健康委员会急诊医学质控中心, 中国医师协会急诊医师分会, 世界中医药学会联合会急症专业委员会.中国急性缺血性脑卒中急诊诊治专家共识[J].中国急救医学, 2018, 38(4):281-287. [6] Wu, S.&B.Wu.&M.Liu, et al.Stroke in China:advances and challenges in epidemiology, prevention, and management[J].Lancet Neurol, 2019, 18(4):394-405. [7] 中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组.中国急性脑梗死后出血转化诊治共识2019[J].中华神经科杂志, 2019, 52(4):252-265. [8] 潘景江, 余翔, 刘斌.CTP联合mCTA对急性缺血性脑卒中取栓后出血性转化(PH2型)的预测[J].临床放射学杂志, 2023, 42(5):722-728. [9] I.Tsogkas, M.Knauth, K.Schregel, et al.CT灌注与CT血管成像相比预测卒中病人机械取栓后临床转归的附加价值[J].国际医学放射学杂志, 2017, 40(1):108-109. [10] 张清清, 傅聪, 傅新民, 等.基于颅脑CT灌注成像筛选的急性基底动脉闭塞性脑梗死的血管内再通治疗临床研究[J].生物医学工程与临床, 2021, 25(2):155-159. [11] 余翔, 赵小英, 潘景江, 等.多时相CT血管成像评估急性缺血性脑卒中机械取栓后的风险与获益[J].临床放射学杂志, 2021, 40(9):1675-1681. [12] 王庆松, 张圣, 张美霞, 等.基于CT灌注成像的侧支评分预测急性前循环大血管闭塞患者动脉取栓治疗预后的价值[J].浙江大学学报(医学版), 2017, 46(4):377-383. |
[1] |
Ma Hongwu, Wu Weixuan, Fan Haoqin, Chen Xueyan. Predictive Value of Inflammatory Prognostic Index Combined with IL-11 for Immune Related Adverse Reactions in Advanced Non-small Cell Lung Cancer[J]. journal1, 2023, 43(5): 49-51. |
[2] |
. [J]. journal1, 2023, 43(5): 57-58. |
[3] |
Ma Yan, Ding Yong, Wang Chenmeng. Effect of CRRT on Nutrition and Micro Inflammation in Patients with Severe Infection[J]. journal1, 2023, 43(4): 18-20. |
[4] |
. [J]. journal1, 2023, 43(4): 50-52. |
[5] |
Gao limei. Correlation Between Serum HB-EGF and GDF15 Levels and Prognosis of Ovarian Cancer Patients undergoing Surgical Treatment[J]. journal1, 2023, 43(3): 43-45. |
[6] |
. [J]. journal1, 2023, 43(3): 61-62. |
|
|
|
|